TRIAL DETAIL

A Trial of PT2977 Tablets In Patients With Advanced Solid Tumors

Drug:
Trial Name:
A Trial of PT2977 Tablets In Patients With Advanced Solid Tumors
NCT#:
Conditions:
Solid Tumors
Status:
Recruiting
Phase:
1
Start Date 12/01/2016
Age of Trial (yrs) 2.8
Treatment Phase:
Gleevec-resistant
Drug Category:
HIF-2a Inhibitor
Strategy:
Modify tumor microenvironment
Trial Type:
GIST not specified. GIST patient enrollment unknown.
Other Protocol IDs:
PT2977-101
Sponsor:
Peloton Therapeutics, Inc.
Patient Contact:
Richard Kelley 972-629-4088 clinicalstudies@pelotontx.com
Contact email:
Contact Phone:
Randomized:
IV or Oral:
Oral
Trial Notes:

Trial Links

Trial Results

Drug Information

PT2977 Poster from Peloton
 

Trial Sites

Name
Address
City
State
Zip
Country
1475 Northwest 12th Ave
Miami
FL
33136
USA
450 Brookline Ave
Boston
MA
02215-5450
USA
330 Brookline Ave.
Boston
MA
02215
USA
55 Fruit Street
Boston
MA
02114
USA
Medical Center Boulevard
Winston-Salem
NC
27157
USA
Nashville
TN
37203
USA
4319 Medical Dr.
San Antonio
TX
78229
USA